Home » Topics » Regulatory » Patents

Patents
RSS

New antimigraine agents disclosed by Merck & Co.

Oct. 18, 1996

Merck & Co. reveals new series of tachykinin antagonists

Oct. 18, 1996

Nissan Chem. claims hypoglycemic agents for diabetes

Oct. 11, 1996

New hepatoprotectants from Nisshin Flour Milling

Oct. 11, 1996

Zenyaku Kogyo discloses anti-Helicobacter pylori agents

Oct. 11, 1996

Integrin receptor antagonists described by SKB

Oct. 11, 1996

Antiplatelet fibrinogen antagonists from Yamanouchi

Oct. 11, 1996

Fibrinogen antagonist research continues at Merck & Co.

Oct. 11, 1996

MTP inhibitors from Bristol-Myers Squibb

Oct. 11, 1996

Wakunaga discloses angiotensin II antagonists

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...